Dr Emmanuel Adewuyi is an NHMRC Investigator Fellow in the Curtin School of Population Health and a multidisciplinary research leader with expertise in human genomic epidemiology, statistical genetics, perinatal epidemiology and population health. Within the Epidemiology Research Lab, he leads research in human genomic epidemiology and statistical genetics, integrating population-scale genomic, multi-omic and epidemiological data to investigate the genetic architecture and biological mechanisms of complex human diseases. His broader methodological expertise spans genome-wide and cross-trait genetic analyses, Mendelian randomisation and causal inference, gene-based and regulatory analyses, integrative multi-omics, and population-based epidemiological methods.

He leads an NHMRC-funded research program investigating the biological mechanisms of dementia through the genetic dissection of disease comorbidities and is a member of the Dementia Centre of Excellence within the Curtin enAble Institute. His research examines why complex diseases co-occur, whether these relationships reflect shared or distinct genetic influences, and how genomic and molecular evidence can reveal underlying biological pathways and prioritise potential therapeutic targets. Beyond dementia, Dr Adewuyi applies genomic epidemiology and statistical genetics across diverse neurological, neuropsychiatric, metabolic, cardiovascular, immune-related, gastrointestinal and reproductive conditions, using human genetic and epidemiological evidence to advance understanding of disease aetiology, comorbidity and underlying mechanisms.

Dr Adewuyi also has an established research program in perinatal epidemiology and maternal and child health. His population-based research investigates maternal, pregnancy, perinatal and child health outcomes and associated health inequalities, particularly in low- and middle-income settings. His research further extends to pharmacoepidemiology and pharmaco(epi)genetics, bridging his expertise in genomic and perinatal epidemiology. As an International Alliance for PharmacoGenetic Epidemiology Excellence (iAPOGEE) Visiting Fellow, he led an international collaborative research programme with the University of Oslo and Oslo University Hospital, integrating perinatal pharmacoepidemiology, genomics and epigenetics to investigate medication exposures during pregnancy and their implications for offspring health.

Dr Adewuyi’s research career has been supported by competitive funding. His achievements have received national and international recognition, including an Australia Awards Scholarship and Global Distinguished Talent recognition for academic and research excellence. His research has generated academic, policy and public impact, attracting international media attention and informing policy and professional guidance. He also advances research capacity through supervision, mentorship and international collaboration, while contributing to the scientific community through grant assessment, editorial leadership and peer review.